(Q42996661)

12 November 2017

title

Influence of HLA alleles on outcome of hepatitis C virus infection (English)

1 reference

12 November 2017

1 reference

H M Diepolder

1

1 reference

12 November 2017

S Scholz

series ordinal

2

1 reference

12 November 2017

G R Pape

series ordinal

3

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

12 November 2017

1 reference

12 November 2017

volume

354

1 reference

12 November 2017

issue

9196

1 reference

12 November 2017

page(s)

2094-2095

1 reference

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900327-X

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900327-X

7 January 2021

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900327-X

7 January 2021

Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900327-X

7 January 2021

Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900327-X

7 January 2021

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900327-X

7 January 2021

Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900327-X

7 January 2021

10.1016/S0140-6736(99)00327-X

Identifiers

DOI

1 reference

12 November 2017

1 reference